Itafos Reports Outstanding Q3 2025 Performance and Mechanical Completion of the H1/NDR Mine

HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company”) today reported its Q3 2025 financial results and provided a corporate update. The Company’s financial statements and management’s discussion and analysis for the three and nine months ended September 30, 2025 are available under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.itafos.com. All figures are in thousands of US Dollars except as otherwise noted. A recorded webcast of management’s commentary reviewing the Q3 2025 financial results and an update on the business will be available on the Company’s website on Monday, November 10, 2025 (see details below). CEO Commentary Chief Executive Officer, David Delaney commented, “we are pleased to report another highly successful quarter in which the Company maintained its exceptional operational and safety performance. We were able to take advantage of a fundamentally strong phosphate market by sustaining industry-leading production rates at Conda and sales volume growth through the introduction of new dry fertilizer products at Arraias. Adjusted EBITDA1 increased by over $17 million compared to the prior quarter and by almost $11 million on a year-over-year basis despite continued elevated raw material costs. Total adjusted EBITDA of nearly $49 million was the highest level since the fourth quarter of 2022. We have finished mining at Rasmussen Valley and have begun the reclamation process at the site. The Husky 1 / North Dry Ridge (“H1/NDR”) infrastructure build-out is mechanically complete and stockpiles from the new mines should allow the Conda plant to continue to produce at current operating rates. Our resource delineation drilling program has commenced with further activities planned for 2026 and beyond to define the resources at our current leases and leverage our existing infrastructure with the ultimate goal to extend our mine life well beyond the current 2037 plan. In October, we successfully monetized the equity interest in St George Mining Limited (“St George”) that was received as consideration for the sale of our Araxá Project. The sale of shares and the exercise of options generated gross proceeds of $21.8 million before taxes, fees and associated expenses. In addition, St. George elected to pay the final two instalments ahead of schedule and we have received the final US$11 million (less withholding tax payable) due under the sale agreement of the Araxa Project. Following these transactions, we are pleased to announce our Board of Directors has approved a CAD$0.17 per share special dividend payable on December 11, 2025 with a record date of November 17, 2025. This will bring total distributions associated with the Araxá sale to CAD$0.22 per share. Although phosphate prices have moderated off recent highs driven by farmer affordability concerns, tight supply / demand dynamics remain. Looking forward, we believe the Company is well positioned to benefit from a fundamentally tight international phosphate market subject to normal seasonal price resets.” Q3 2025 Financial Highlights For Q3 2025, the Company’s financial highlights were as follows: Revenues of $152.8 million in Q3 2025 compared to $120.0 million in Q3 2024; Adjusted EBITDA1 of $48.9 million in Q3 2025 compared to $38.0 million in Q3 2024; Net income of $36.2 million in Q3 2025 compared to $18.3 million in Q3 2024; Basic earnings1 of C$0.26/share in Q3 2025 compared to C$0.13/share in Q3 2024; and Free cash flow1 of $(4.8) million in Q3 2024 compared to $(22.4) million in Q3 2024. The increase in the Company’s Q3 2025 adjusted EBITDA compared to the corresponding period in the prior year was due to higher revenues, which were partially offset by higher input sulfur and sulfuric acid costs at Conda. The increase in the Company’s Q3 2025 net income compared to Q3 2024 was primarily due to higher gross margin and fair value gain on investments, which were partially offset by higher finance expenses and higher income tax expense. The Company’s total capex2 spend in Q3 2025 was $21.6 million compared to $21.1 million in Q3 2024, which remained relatively consistent year-over-year. 9M 2025 Financial Highlights For 9M 2025, the Company’s financial highlights were as follows: Revenues of $415.4 million in 9M 2025 compared to $353.1 million in 9M 2024; Adjusted EBITDA of $120.0 million in 9M 2025 compared to $114.0 million in 9M 2024; Net income of $96.9 million in 9M 2025 compared to $58.2 million in 9M 2024; Basic earnings of C$0.70/share in 9M 2025 compared to C$0.41/share in 9M 2024; and Free cash flow of $37.3 million in 9M 2025 compared to $37.8 million in 9M 2024. The increase in the Company’s 9M 2025 adjusted EBITDA compared to 9M 2024 was primarily due to higher revenues, which were partially offset by higher sulfur and sulfuric acid costs at Conda. The increase in the Company’s 9M 2025 net income compared to 9M 2024 was primarily due to higher gross margin, the gain on the sale of the Araxá Project, fair value gain on investment and lower finance expenses, which were partially offset by withholding tax expenses related to the sale of the Araxá Project. The Company’s total capex spend in 9M 2025 was $60.3 million compared to $57.7 million in 9M 2024 with the increase primarily due to development activities at Conda (H1/NDR and magnesium oxide reduction initiatives), and activities related to the fertilizer restart program at Arraias (the “Fertilizer Restart Program”). As of September 30, 2025, the Company’s financial highlights were as follows: Trailing 12 months Adjusted EBITDA2 of $165.5 million; Net debt2 of $6.1 million; and Net leverage ratio2 of 0.0x. Recent Developments Equity interest in St George On October 16, 2025, the Company announced that it partially monetized its ownership interest in St George that it acquired as consideration for the sale of its Araxá Project, announced in February 2025. Between October 13 and 14, 2025, the Company sold 277,893,103 SGQ Shares. On October 16, 2025, the Company issued an exercise notice to exercise the 86,111,025 options at AUD$0.04 per share. Between October 21 and 22, 2025, the Company sold the remaining 86,111,025 SGQ Shares. The total net proceeds received from the sale of 364,004,128 SGQ Shares was $21.8 million, net of the exercise price of the options. Sale of the Araxá Project On November 5, 2025, St George made payment of the deferred cash consideration totaling $11 million (less withholding tax payable) due to the Company under the second and third instalments of the Sale Agreement relating to the acquisition by St George of the 100% interest in the Araxá Rare Earths and Niobium Project in Minas Gerais, Brazil (the “Araxá Project”). As a result of the payment, the Araxa Project sale transaction has been completed. Special Dividend The Board of Directors has approved a CAD$0.17 per share special dividend payable on December 11, 2025 to shareholders of record as of the close of business on November 17, 2025. Registered shareholders who are Canadian residents as reflected in the Company’s shareholder register will receive their dividend in Canadian dollars. Registered shareholders who are resident outside of Canada as reflected in the Company’s shareholder register, including the United States (“U.S.”), will receive their dividend in U.S. dollars, based on the spot price exchange rate calculated on December 11, 2025. Intermediaries who are CDS participants may elect to have the dividend paid in U.S. dollars. Shareholders who hold their shares through a broker or intermediary should contact their broker or intermediary directly for further details. Dividend payments to shareholders will generally be subject to Internal Revenue Service withholding tax unless reduced through the completion of tax election forms and/or in accordance with the provisions of an applicable tax treaty. Both U.S. and non-U.S. resident registered shareholders should complete the appropriate tax forms and submit them to Itafos’ transfer agent, TSX Trust Company, to be entitled to a reduced withholding tax rate. Shareholders who hold their shares through a broker or intermediary should contact their broker or intermediary directly for further details. FY 2025 Market and Financial Outlook Market Outlook Phosphate fertilizer prices were elevated in Q3 2025 compared to the previous quarter, driven by continued constraints on diammonium phosphate (“DAP”) and monoammonium phosphate (“MAP”) exports from China and ongoing uncertainty surrounding US trade policy, which has limited phosphate imports. While prices have moderated off the Q3 highs, prices today remain above the historical five-year average price. Despite strong global demand, low grain and oilseed prices continue to weigh on phosphate affordability. DAP and MAP prices relative to crop values are near 20-year lows in terms of US farmer purchasing power. With a large US corn crop currently being harvested and China continuing to source soybeans from competing suppliers, US affordability challenges are expected to persist in the near term. However, with constrained domestic supply and steady global consumption, phosphate prices are expected to remain supported at historically elevated levels in the short run. Looking ahead, the Company anticipates a modest softening in phosphate prices through Q4 2025 due to: Continued weak US farmer affordability offset by a typical winter price reset to stimulate retail demand ahead of the 2026 planting season; ongoing export restrictions from China; lower US MAP production; and ongoing uncertainty surrounding US phosphate import tariffs. Financial Outlook The Company revised its guidance for 2025 as follows: (in millions of US Dollars Projected except as otherwise noted) FY 2025 Sales Volumes (thousands of tonnes P2O5)3 345-355 Corporate selling, general and administrative expenses4 $15-17 Maintenance capex4 $16-20 Growth capex4 $60-70 Environmental and asset retirement obligations payments $6-8     Q3 and 9M 2025 Market Highlights MAP New Orleans (“NOLA”) prices averaged $779/st in Q3 2025 compared to $636/st in Q3 2024, up 22% year-over-year, and averaged $688/st in 9M 2025 compared to $606/st in 9M 2024, up 14% year-over-year. Specific factors driving the year-over-year increase in MAP NOLA prices were as follows: lower than expected Chinese exports of MAP; continued strong global demand, particularly from Africa, India and Brazil; and uncertainty surrounding US trade policy and imposition of tariffs on imported products. September 30, 2025, Highlights As of September 30, 2025, the Company had trailing 12 months Adjusted EBITDA of $165.5 million compared to $159.5 million as of December 31, 2024 with the increase primarily due to the same factors that resulted in higher Adjusted EBITDA during Q3 2025 as compared to Q3 2024 described above. As of September 30, 2025, the Company had net debt of $6.1 million compared to $26.8 million as of December 31, 2024, with the reduction primarily due to higher cash and cash equivalents and lower debt balances. The Company’s net debt as of September 30, 2025 was comprised of $86.7 million in cash and $92.8 million in debt (gross of deferred financing costs). As of September 30, 2025 and the end of 2024, the Company’s net leverage ratio was 0.0x and 0.2x, respectively. As of September 30, 2025, the Company had liquidity4 of $166.7 million comprised of $86.7 million in cash and $80.0 million in undrawn borrowing capacity under its $80.0 million asset-based revolving credit facility (“ABL Facility”). Operations Highlights and Mine Development Environmental, Health, and Safety (“EHS”) For Q3 2025, the Company sustained EHS performance, including no reportable environmental releases and three recordable incidents, which resulted in a consolidated total recordable incident frequency rate (“TRIFR”) of 0.54. For 9M 2025, the Company sustained EHS performance, including no reportable environmental releases and five recordable incidents, which resulted in a consolidated TRIFR of 0.54. Conda In Q3 2025, Conda Produced 91,219 tonnes P2O5 compared to 92,311 tonnes P2O5 in Q3 2024, which remained relatively consistent year-over-year with higher MAP volumes offset by lower SPA volumes; Generated revenues of $134.0 million compared to $110.7 million in Q3 2024 with the increase primarily due to higher realized prices for MAP and SPA products resulting from strong phosphate market dynamics; and Generated Adjusted EBITDA of $46.3 million compared to $37.7 million in Q3 2024 with the increase primarily due to higher realized prices from market strength outpacing higher sulfur and sulfuric acid costs. In 9M 2025, Conda: Produced 262,025 tonnes P2O5 compared to 252,090 tonnes P2O5 in 9M 2024 with the increase primarily due to a planned short turnaround in 2025 (10 days) compared to a planned large scope turnaround in 2024 (25 days) and higher P2O5 production from higher throughput from strong plant performance; Generated revenues of $379.0 million compared to $335.4 million in 9M 2024 with the increase primarily due to higher realized prices for MAP and SPA products resulting from strong phosphate market dynamics; and Generated Adjusted EBITDA of $120.1 million compared to $121.4 million in 9M 2024 with the increase primarily due to higher realized prices from market strength outpacing higher sulfur and sulfuric acid costs. Completion of Mining at Rasmussen Valley The Company completed mining at the Rasmussen Valley mine in Q3 2025 after approximately seven years in operation, with reclamation activities expected to commence in Q4 2025. Expected reclamation costs for the Rasmussen Valley mine are expected to be in the range of $80 to $100 million with the majority of the spend to occur over the next 48 months. Mine Life Extension For the three and nine months ended September 30, 2025, the Company advanced activities related to the extension of Conda’s mine life through the development of H1/NDR as follows: advanced H1/NDR capital activities including construction of rail loading facilities and mine development; and in June 2025, the Company received authorization from the Board of Directors to proceed with a capital project to construct a new processing facility designed to lower the magnesium content of the ore from the H1/NDR mines in order to maintain P2O5 production capacity at the plant (the “MgO Reduction Project”). Exploration and Appraisal Program at Conda As capital work at H1/NDR continues with first ore shipments expected in Q4 2025, the Company is focused on identifying and pursuing opportunities to add additional resources and reserves to the project to extend mine life beyond the current NI 43-101 - Standards of Disclosures for Mineral Projects (“NI 43-101”) estimate of mid-2037. To pursue this objective, the Company has commenced a multi-year, multi-lease exploration program, resource evaluation and permitting program at Conda with an expected annual cost of approximately $6-8 million. The in-fill drilling program is focused on further delineating upside potential of the Husky 1 Lease through a targeted reserve delineation appraisal that will reduce drill spacing to 250ft on center versus current spacing at 500ft. Initial resource delineation drilling on the Dry Ridge Lease commenced in Q3 2025, with the initial program consisting of drilling on 2,400ft centers to gain crucial geologic and metallurgical information that will be used to generate initial resource models that will drive future mine planning resource estimation and permitting studies. Core drilling and geologic modeling of the Husky 3 and Husky 4 Leases is ahead of schedule as exploration core drilling commenced in September 2025. This initial drilling will identify the site geology and characterize the resource for future mine development along the current mine trend. In addition to these activities, preliminary work has commenced on environmental baseline resource studies that will be required for future National Environmental Policy Act permitting and regulatory approvals. These geographically near field opportunities have the potential to extend mine life beyond the current NI 43-101 estimate of mid-2037 in an efficient manner with the objective of utilizing the current infrastructure being built out at H1/NDR. Arraias In Q3 2025, Arraias: Produced 26,164 tonnes of excess sulfuric acid compared to 28,483 tonnes in Q3 2024 with the decreased due to due to higher acid consumption with the start of Partially Acidulated Phosphate Rock (“PAPR”) and Granulated Partially Acidulated Phosphate Rock (“G-PAPR”) production; Produced 29,564 tonnes P2O5, compared to 12,719 tonnes P2O5 in Q3 2024, with the increase due to ramp up of Direct Application Phosphate Rock (“DAPR”) and PAPR production and the restart of the granulation plant to produce G-PAPR, as part of the Fertilizer Restart Program; and Generated Adjusted EBITDA of $7.0 million compared to $3.7 million in Q3 2024 with the increase primarily due to sulfuric acid gross margin improvement driven by higher sales prices. In addition, the increase reflects higher sales of fertilizer products sales during Q3 2025, particularly due to the contribution from G-PAPR. In 9M 2025, Arraias: Produced 92,812 tonnes of excess sulfuric acid compared to 78,011 tonnes in 9M 2024 driven by higher customer demand; Produced 40,291 tonnes P2O5 of DAPR and PAPR compared to 16,513 tonnes P2O5 in 9M 2024, with the increase driven by higher demand for fertilizer products in line with seasonal market trends. In addition, significant sales of DAPR and PAPR, along with the start of G-PAPR sales, have supported this growth; and Generated Adjusted EBITDA of $12.5 million compared to $3.5 million in 9M 2024 with the increase primarily due to a combination of higher sulfuric acid gross margin driven by higher sales prices and higher volume coupled with higher fertilizer products sales in 2025, driven by significant higher sales volumes including the addition of the new product G-PAPR. Q3 2025 Financial Results and Business Update Webcast An on-demand recorded webcast of management commentary that reviews the Q3 2025 financial results, provides an update on the business and addresses analysts’ and investors’ recent frequently asked questions will be available on Monday, November 10, 2025 at 4:30 p.m. ET. The webcast will be available on the Presentations & Events page of the Company’s website www.itafos.com/investors/presentations-fact-sheets/ and will be available for 90 days. About Itafos The Company is a phosphate and specialty fertilizer company with businesses and projects spanning three continents: Conda – a vertically integrated phosphate fertilizer business located in Idaho, US, with the following production capacity: approximately 550kt per year of MAP, MAP with micronutrients (“MAP+”), superphosphoric acid (“SPA”), merchant grade phosphoric acid (“MGA”) and ammonium polyphosphate (“APP”) approximately 27kt per year of hydrofluorosilicic acid (“HFSA”) Arraias – a vertically integrated phosphate fertilizer business located in Tocantins,Brazil, with the following production capacity: approximately 500kt per year of single superphosphate (“SSP”) and SSP with micronutrients (“SSP+”) approximately 40kt per year of excess sulfuric acid (220kt per year gross sulfuric acid production capacity) Farim – a high-grade phosphate mine project located in Farim, Guinea-Bissau; and Santana – a vertically integrated high-grade phosphate mine and fertilizer plant project located in Pará, Brazil The Company is a Delaware corporation headquartered in Houston, Texas. The Company’s shares trade on the TSX-V under the ticker “IFOS”. The Company’s shares also trade in the US on the OTCQX® Best Market (“OTCQX”) under the ticker symbol “ITFS”. The Company’s principal shareholder is CL Fertilizers Holding LLC (“CLF”). CLF is an affiliate of global private investment firm Castlelake, L.P. For more information, or to join the Company’s mailing list, please visit www.itafos.com. Forward-Looking Information Certain information contained in this news release constitutes forward-looking information, including statements with respect to: the sale of the Araxá Project; the special dividend; Company guidance; import and export tariffs; the Company’s planned operations, strategies and projects, including the MgO Reduction Project; the timing for the commencement of operations and first ore at H1/NDR; the expected resource life of H1/NDR; exploration activities to extend mine life; and economic and market trends with respect to the global agriculture and phosphate fertilizer markets. All information other than information of historical fact is forward-looking information. Statements that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future include, but are not limited to, statements regarding estimates and/or assumptions in respect of the Company’s financial and business outlook are forward-looking information. The use of any of the words “intend”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “would”, “believe”, “predict” and “potential” and similar expressions are intended to identify forward-looking information. The forward-looking information contained in this news release is based on the opinions, assumptions and estimates of management, some of which are set out herein, which management believes are reasonable as at the date the statements are made. Those opinions, assumptions and estimates are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual events or results to differ materially from those projected in the forward-looking information. These include the Company’s expectations and assumptions with respect to the following: commodity prices; operating results; safety risks; changes to the Company’s mineral reserves and resources; risk that timing of expected permitting will not be met; changes to mine development and completion; foreign operations risks; changes to regulation; environmental risks; the impact of weather and climate change; risks related to asset retirement obligations, general economic changes, including inflation and foreign exchange rates; the actions of the Company’s competitors and counterparties; financing, liquidity, credit and capital risks; the loss of key personnel; impairment risks; cybersecurity risks; risks relating to transportation and infrastructure; changes to equipment and suppliers; concentration risks, adverse litigation; changes to permitting and licensing; geo-political risks; loss of land title and access rights; changes to insurance and uninsured risks; the potential for malicious acts; market and stock price volatility; changes to technology, innovation or artificial intelligence; changes to tax laws; the risk of operating in foreign jurisdictions; the risks posed by a controlling shareholder and other conflicts of interest; risks related to reputational damage, the risk associated with epidemics, pandemics and public health; the risks associated with environmental justice; and any risks related to internal controls over financial reporting risks. Readers are cautioned that the foregoing list of risks, uncertainties and assumptions is not exhaustive. Although the Company has attempted to identify crucial factors that could cause actual actions, events or results to differ materially from those described in the forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Additional risks and uncertainties affecting the forward-looking information contained in this news release are described in greater detail in the Company’s Annual Information Form and current Management’s Discussion and Analysis available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.itafos.com. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. The reader is cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates, assumptions or opinions should change, except as required by applicable securities law. The forward-looking information included in this news release is expressly qualified by this cautionary statement and is made as of the date of this news release. This news release contains future-oriented financial information and financial outlook information (together, “FOFI”) about the Company’s prospective results of operations, including statements regarding expected Adjusted EBITDA, net income, basic earnings per share, corporate selling, general and administrative expenses, maintenance capex, growth capex and free cash flow. FOFI is subject to the same assumptions, risk factors, limitations and qualifications as set forth in the above paragraph. The Company has included the FOFI to provide an outlook of management’s expectations regarding anticipated activities and results, and such information may not be appropriate for other purposes. The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management’s reasonable estimates and judgements; however, actual results of operations and the resulting financial results may vary from the amounts set forth herein. Any financial outlook information speaks only as of the date on which it is made and the Company undertakes no obligation to publicly update or revise any financial outlook information except as required by applicable securities laws. NEITHER THE TSX-V NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-V) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. Contacts: For Investor Relations: Matthew O’Neill Executive Vice President & Chief Financial Officer [email protected] 713-242-8446 For Media: Alliance Advisors IR Fatema Bhabrawala Director, Media Relations [email protected] 647-620-5002 Scientific and Technical Information The scientific and technical information contained in this news release related to Mineral Resources for Conda has been reviewed and approved by Jerry DeWolfe, Professional Geologist (P.Geo.) with the Association of Professional Engineers and Geoscientists of Alberta. Mr. DeWolfe is a full-time employee of WSP Canada Inc. and is independent of the Company. The scientific and technical information contained in this news release related to Mineral Reserves for Conda has been reviewed and approved by Terry Kremmel, Professional Engineer (P.E.) licensed by the States of Missouri and North Carolina. Mr. Kremmel is a full-time employee of WSP USA, Inc. and is independent of the Company. The Company’s latest technical report in respect of Conda is entitled, “NI 43-101 Technical Report Itafos Conda Project, Idaho, USA,” with an effective date of July 1, 2023 and is available under the Company’s website at www.itafos.com and under the Company’s profile on SEDAR+ at www.sedarplus.ca. Non-IFRS Financial Measures This press release contains both IFRS and certain non-IFRS measures that management considers to evaluate the Company’s operational and financial performance. Non-IFRS measures are a numerical measure of a company’s performance, that either include or exclude amounts that are not normally included or excluded from the most directly comparable IFRS measures. Management believes that the non-IFRS measures provide useful supplemental information to investors, analysts, lenders and others. In evaluating non-IFRS measures, investors, analysts, lenders and others should consider that non-IFRS measures do not have any standardized meaning under IFRS and that the methodology applied by the Company in calculating such non-IFRS measures may differ among companies and analysts. Non-IFRS measures should not be considered as a substitute for, nor superior to, measures of financial performance prepared in accordance with IFRS. Definitions and reconciliations of non-IFRS measures to the most directly comparable IFRS measures are included below. DEFINITIONS The Company defines its non-IFRS measures as follows: Non-IFRS measure Definition Most directly comparable IFRS measure Why the Company uses the measure EBITDA Earnings before interest, taxes, depreciation, depletion and amortization Net income (loss) and operating income (loss) EBITDA is a valuable indicator of the Company’s ability to generate operating income Adjusted EBITDA EBITDA adjusted for non-cash, extraordinary, non-recurring and other items unrelated to the Company’s core operating activities Net income (loss) and operating income (loss) Adjusted EBITDA is a valuable indicator of the Company’s ability to generate operating income from its core operating activities normalized to remove the impact of non-cash, extraordinary and non-recurring items. The Company provides guidance on Adjusted EBITDA as useful supplemental information to investors, analysts, lenders, and others Basic earnings (C$/share) Basic earnings per share denominated in US dollars ($/share) divided by the average exchange rate C$/$ during the period. Basic earnings ($/share) The Company considers that basic earnings (C$/share) is a useful indicator to investors given that the Company’s shares primarily trade in C$ Trailing 12 months Adjusted EBITDA Adjusted EBITDA for the current and preceding three quarters Net income (loss) and operating income (loss) for the current and preceding three quarters The Company uses the trailing 12 months Adjusted EBITDA in the calculation of the net leverage ratio (non-IFRS measure) Total capex Additions to property, plant, and equipment and mineral properties adjusted for additions to asset retirement obligations, additions to right-of-use assets and capitalized interest Additions to property, plant and equipment and mineral properties The Company uses total capex in the calculation of total cash capex (non-IFRS measure) Maintenance capex Portion of total capex relating to the maintenance of ongoing operations Additions to property, plant and equipment and mineral properties Maintenance capex is a valuable indicator of the Company’s required capital expenditures to sustain operations at existing levels Growth capex Portion of total capex relating to the development of growth opportunities Additions to property, plant and equipment and mineral properties Growth capex is a valuable indicator of the Company’s capital expenditures related to growth opportunities. Total cash capex Total capex less accrued capex Additions to property, plant and equipment and mineral properties The Company uses total cash capex in the calculation of cash growth capex (non-IFRS measure) Cash maintenance capex Maintenance capex less accrued maintenance capex Additions to property, plant and equipment and mineral properties The Company uses cash maintenance capex in the calculation of cash growth capex (non-IFRS measure) Cash growth capex Growth capex less accrued growth capex Additions to property, plant and equipment and mineral properties The Company uses cash growth capex in the calculation of free cash flow (non-IFRS measure). Net debt Debt less cash and cash equivalents plus deferred financing costs (does not consider lease liabilities) Current debt, long-term debt and cash and cash equivalents Net debt is a valuable indicator of the Company’s net debt position as it removes the impact of deferring financing costs. Net leverage ratio Net debt divided by trailing 12 months Adjusted EBITDA Current debt, long-term debt and cash and cash equivalents; net income (loss) and operating income (loss) for the current and preceding three quarters The Company’s net leverage ratio is a valuable indicator of its ability to service its debt from its core operating activities. Liquidity Cash and cash equivalents plus undrawn committed borrowing capacity Cash and cash equivalents Liquidity is a valuable indicator of the Company’s liquidity Free cash flow Cash flows from operating activities, which excludes payment of interest expense, plus cash flows from investing activities Cash flows from operating activities and cash flows from investing activities Free cash flow is a valuable indicator of the Company’s ability to generate cash flows from operations after giving effect to required capital expenditures to sustain operations at existing levels. Free cash flow is a valuable indicator of the Company’s cash flow available for debt service or to fund growth opportunities. The Company provides guidance on free cash flow as useful supplemental information to investors, analysts, lenders, and others. Corporate selling, general and administrative expenses Corporate selling, general and administrative less share-based payments expense. Selling, general and administrative expenses The Company uses corporate selling, general and administrative expenses to assess corporate performance.         EBITDA, ADJUSTED EBITDA AND TRAILING 12 MONTHS ADJUSTED EBITDA For the three months ended September 30, 2025 and 2024 For the three months ended September 30, 2025, the Company had EBITDA and Adjusted EBITDA by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Net income (loss) $ 23,863     $ 5,798     $ (362 )   $ 6,919     $ 36,218   Finance (income) expense, net   1,196       (153 )     —       642       1,685   Current and deferred income tax expense   7,755       —       —       1,198       8,953   Depreciation and depletion   13,230       859       —       78       14,167   EBITDA $ 46,044     $ 6,504     $ (362 )   $ 8,837     $ 61,023   Unrealized foreign exchange loss   —       70       54       —       124   Share-based payment expense   —       —       —       658       658   Transaction costs   —       —       —       26       26   Other (income) expense, net   251       474       —       (13,660 )     (12,935 ) Adjusted EBITDA $ 46,295     $ 7,048     $ (308 )   $ (4,139 )   $ 48,896                                           (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Operating income (loss) $ 33,067     $ 6,189     $ (308 )   $ (4,883 )   $ 34,065   Depreciation and depletion   13,230       859       —       78       14,167   Realized foreign exchange gain   (2 )     —       —       (18 )     (20 ) Share-based payment expense   —       —       —       658       658   Transaction costs   —       —       —       26       26   Adjusted EBITDA $ 46,295     $ 7,048     $ (308 )   $ (4,139 )   $ 48,896                                           For the three months ended September 30, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Net income (loss) $ 17,928     $ 3,271     $ (11 )   $ (2,902 )   $ 18,286   Finance (income) expense, net   1,083       (139 )     1       395       1,340   Current and deferred income tax expense (recovery)   8,573       —       —       (2,175 )     6,398   Depreciation and depletion   9,658       458       3       82       10,201   EBITDA $ 37,242     $ 3,590     $ (7 )   $ (4,600 )     36,225   Unrealized foreign exchange loss   —       54       60       —       114   Share-based payment expense   —       —       —       734       734   Transaction costs   —       —       —       481       481   Other expense   439       16       2       —       457   Adjusted EBITDA $ 37,681     $ 3,660     $ 55     $ (3,385 )   $ 38,011                                           (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Operating income (loss) $ 28,021     $ 3,202     $ 52     $ (4,681 )   $ 26,594   Depreciation and depletion   9,658       458       3       82       10,201   Realized foreign exchange gain   2       —       —       (1 )     1   Share-based payment expense   —       —       —       734       734   Transaction costs   —       —       —       481       481   Adjusted EBITDA $ 37,681     $ 3,660     $ 55     $ (3,385 )   $ 38,011                                           For the nine months ended September 30, 2025 and 2024 For the nine months ended September 30, 2025, the Company had EBITDA and Adjusted EBITDA by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Net income (loss) $ 67,279     $ 10,278     $ (1,224 )   $ 20,575     $ 96,908   Finance (income) expense, net   3,666       (458 )     —       3,142       6,350   Current and deferred income tax expense   19,771       —       —       3,151       22,922   Depreciation and depletion   28,604       2,152       —       232       30,988   EBITDA $ 119,320     $ 11,972     $ (1,224 )   $ 27,100     $ 157,168   Unrealized foreign exchange (gain) loss   —       (188 )     318       —       130   Share-based payment expense   —       —       —       4,535       4,535   Transaction costs   —       —       —       130       130   Other (income) expense, net   762       686       —       (43,409 )     (41,961 ) Adjusted EBITDA $ 120,082     $ 12,470     $ (906 )   $ (11,644 )   $ 120,002                                           (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Operating income (loss) $ 91,484     $ 10,318     $ (906 )   $ (16,239 )   $ 84,657   Depreciation and depletion   28,604       2,152       —       232       30,988   Realized foreign exchange loss   (6 )     —       —       (302 )     (308 ) Share-based payment expense   —       —       —       4,535       4,535   Transaction costs   —       —       —       130       130   Adjusted EBITDA $ 120,082     $ 12,470     $ (906 )   $ (11,644 )   $ 120,002                                           For the nine months ended September 30, 2024, the Company had EBITDA and Adjusted EBITDA by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Net income (loss) $ 69,911     $ 1,780     $ (239 )   $ (13,243 )   $ 58,209   Finance (income) expense, net   3,470       (597 )     2       5,217       8,092   Current and deferred income tax expense (recovery)   22,343       —       —       (6,567 )     15,776   Depreciation and depletion   24,419       1,653       13       250       26,335   EBITDA $ 120,143     $ 2,836     $ (224 )   $ (14,343 )     108,412   Unrealized foreign exchange (gain) loss   —       1,704       (260 )     —       1,444   Share-based payment expense   —       —       —       1,591       1,591   Transaction costs   —       —       —       708       708   Non-recurring compensation expenses   —       —       —       1,560       1,560   Other (income) expense, net   1,303       (996 )     6       (40 )     273   Adjusted EBITDA $ 121,446     $ 3,544     $ (478 )   $ (10,524 )   $ 113,988                                           (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Operating income (loss) $ 97,030     $ 1,891     $ (491 )   $ (14,623 )   $ 83,807   Depreciation and depletion   24,419       1,653       13       250       26,335   Realized foreign exchange gain   (3 )     —       —       (10 )     (13 ) Share-based payment expense   —       —       —       1,591       1,591   Transaction costs   —       —       —       708       708   Non-recurring compensation expenses   —       —       —       1,560       1,560   Adjusted EBITDA $ 121,446     $ 3,544     $ (478 )   $ (10,524 )   $ 113,988                                           As of September 30, 2025 and December 31, 2024 As of September 30, 2025, and December 31, 2024 the Company had trailing 12 months Adjusted EBITDA5 as follows: (unaudited in thousands of US Dollars) September 30, 2025     December 31, 2024   For the three months ended September 30, 2025 $ 48,896     $ —   For the three months ended June 30, 2025   31,827       —   For the three months ended March 31, 2025   39,279       —   For the three months ended December 31, 2024   45,473       45,473   For the three months ended September 30, 2024   —       38,011   For the three months ended June 30, 2024   —       32,810   For the three months ended March 31, 2024   —       43,167   Trailing 12 months Adjusted EBITDA $ 165,475     $ 159,461                   BASIC EARNINGS (C$/SHARE) For the three and nine months ended September 30, 2025 and 2024, the Company had basic earnings (C$/share) as follows: (unaudited in thousands of US Dollars For the three months ended September 30,     For the nine months ended September 30,   except as otherwise noted) 2025     2024     2025     2024   Basic earnings ($/share) $ 0.19     $ 0.10     $ 0.50     $ 0.30   Basic earnings (C$/share) $ 0.26     $ 0.13     $ 0.70     $ 0.41   Average exchange rate (C$/$)   1.3773       1.3641       1.3988       1.3604                                   TOTAL CAPEX For the three months ended September 30, 2025 and 2024 For the three months ended September 30, 2025, the Company had capex by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Additions to property, plant and equipment $ 24,002     $ 712     $ 28     $ 17     $ 24,759   Additions to mineral properties   (1,346 )     943       67       —       (336 ) Additions to property, plant and equipment related asset retirement obligations   (533 )     (128 )     —       —       (661 ) Additions to right-of-use assets   —       (109 )     —       —       (109 ) Capitalized interest in property, plant, and equipment and mineral properties   (2,066 )     —       —       —       (2,066 ) Total capex $ 20,057     $ 1,418     $ 95     $ 17     $ 21,587   Accrued capex   3,800       —       —       —       3,800   Total cash capex $ 23,857     $ 1,418     $ 95     $ 17     $ 25,387   Maintenance capex $ 2,002     $ 106     $ —     $ 17     $ 2,125   Accrued maintenance capex   467       —       —       —       467   Cash maintenance capex $ 2,469     $ 106     $ —     $ 17     $ 2,592   Growth capex $ 18,055     $ 1,312     $ 95     $ —     $ 19,462   Accrued growth capex   3,333       —       —       —       3,333   Cash growth capex $ 21,388     $ 1,312     $ 95     $ —     $ 22,795                                           For the three months ended September 30, 2024, the Company had capex by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Additions to property, plant and equipment $ 11,633     $ 710     $ —     $ 5     $ 12,348   Additions to mineral properties   18,738       —       108       —       18,846   Additions to property, plant and equipment related asset retirement obligations   (7,261 )     (120 )     —       —       (7,381 ) Additions to right-of-use assets   —       (5 )     —       —       (5 ) Capitalized interest in property, plant, and equipment and mineral properties   (2,714 )     —       —       —       (2,714 ) Total capex $ 20,396     $ 585     $ 108     $ 5     $ 21,094   Accrued capex   8,152       —       —       —       8,152   Total cash capex $ 28,548     $ 585     $ 108     $ 5     $ 29,246   Maintenance capex $ 2,250     $ 324     $ —     $ 5     $ 2,579   Accrued maintenance capex   9,623       —       —       —       9,623   Cash maintenance capex $ 11,873     $ 324     $ —     $ 5     $ 12,202   Growth capex $ 18,146     $ 261     $ 108     $ —     $ 18,515   Accrued growth capex   (1,471 )     —       —       —       (1,471 ) Cash growth capex $ 16,675     $ 261     $ 108     $ —     $ 17,044                                           For the nine months ended September 30, 2025 and 2024 For the nine months ended September 30, 2025, the Company had capex by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Additions to property, plant and equipment $ 64,685     $ 6,116     $ 49     $ 17     $ 70,867   Additions to mineral properties   7,151       1,168       481       —       8,800   Additions to asset retirement obligations   (1,541 )     (760 )     —       —       (2,301 ) Additions to right-of-use assets   (11,710 )     (420 )     (15 )     —       (12,145 ) Capitalized interest in property, plant, and equipment and mineral properties   (4,905 )     —       —       —       (4,905 ) Total capex $ 53,680     $ 6,104     $ 515     $ 17     $ 60,316   Accrued capex   (2,112 )     —       —       —       (2,112 ) Total cash capex $ 51,568     $ 6,104     $ 515     $ 17     $ 58,204   Maintenance capex $ 14,326     $ 217     $ —     $ 17     $ 14,560   Accrued maintenance capex   (108 )     —       —       —       (108 ) Cash maintenance capex $ 14,218     $ 217     $ —     $ 17     $ 14,452   Growth capex $ 39,354     $ 5,887     $ 515     $ —     $ 45,756   Accrued growth capex   (2,004 )     —       —       —       (2,004 ) Cash growth capex $ 37,350     $ 5,887     $ 515     $ —     $ 43,752                                           For the nine months ended September 30, 2024, the Company had capex by segment as follows: (unaudited in thousands of US Dollars) Conda     Arraias     Development and exploration     Corporate     Total   Additions to property, plant and equipment $ 32,475     $ 3,725     $ (2 )   $ 8     $ 36,206   Additions to mineral properties   29,585       —       495       —       30,080   Additions to asset retirement obligations   (6,171 )     646       —       —       (5,525 ) Additions to right-of-use assets   —       (346 )     2       —       (344 ) Capitalized interest in property, plant, and equipment and mineral properties   (2,714 )     —       —       —       (2,714 ) Total capex $ 53,175     $ 4,025     $ 495     $ 8     $ 57,703   Accrued capex   (4,911 )     —       —       —       (4,911 ) Total cash capex $ 48,264     $ 4,025     $ 495     $ 8     $ 52,792   Maintenance capex $ 22,966     $ 2,697     $ —     $ 8     $ 25,671   Accrued maintenance capex   (23 )     —       —       —       (23 ) Cash maintenance capex $ 22,943     $ 2,697     $ —     $ 8     $ 25,648   Growth capex $ 30,209     $ 1,328     $ 495     $ —     $ 32,032   Accrued growth capex   (4,888 )     —       —       —       (4,888 ) Cash growth capex $ 25,321     $ 1,328     $ 495     $ —     $ 27,144                                           NET DEBT AND NET LEVERAGE RATIO As of September 30, 2025, and December 31, 2024 the Company had net debt and net leverage ratio as follows: (unaudited in thousands of US Dollars September 30,     December 31,   except as otherwise noted) 2025     2024   Current debt $ 11,048     $ 11,163   Long-term debt   79,715       86,804   Cash and cash equivalents   (86,681 )     (74,372 ) Deferred financing costs related to the Credit Facilities   1,997       3,207   Net debt $ 6,079     $ 26,802   Trailing 12 months Adjusted EBITDA $ 165,475     $ 159,461   Net leverage ratio 0.0x     0.2x               LIQUIDITY As of September 30, 2025, and December 31, 2024 the Company had liquidity as follows:   September 30,     December 31,   (unaudited in thousands of US Dollars) 2025     2024   Cash and cash equivalents $ 86,681     $ 74,372   ABL Facility undrawn borrowing capacity   80,000       80,000   Liquidity $ 166,681     $ 154,372                   FREE CASH FLOW For the three and nine months ended September 30, 2025 and 2024, the Company had free cash flow as follows:   For the three months ended September 30,     For the nine months ended September 30,   (unaudited in thousands of US Dollars) 2025     2024     2025     2024   Cash flows from operating activities $ 19,753     $ 6,342     $ 85,884     $ 88,853   Cash flows used by investing activities   (24,572 )     (28,771 )     (48,595 )     (51,099 ) Free cash flow $ (4,819 )   $ (22,429 )   $ 37,289     $ 37,754                                   CORPORATE SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES For the three and nine months ended September 30, 2025 and 2024, the Company had corporate selling, general and administrative expenses as follows:   For the three months ended September 30,     For the nine months ended September 30,   (unaudited in thousands of US Dollars) 2025     2024     2025     2024   Selling, general and administrative expenses $ 4,883     $ 4,681     $ 16,239     $ 14,623   Share-based payments expense   (658 )     (734 )     (4,535 )     (1,591 ) Corporate selling, general and administrative expenses $ 4,225     $ 3,947     $ 11,704     $ 13,032                                   ________________________________ 1 Adjusted EBITDA, basic earnings, and free cash flow are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below. International Financial Reporting Standards (“IFRS”). 2 Total capex, trailing 12 months Adjusted EBITDA, net debt, and net leverage ratio are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below. 3 Sales volumes reflect quantity in P2O5 of Conda sales projections. 4 Corporate selling, general and administrative expenses, maintenance capex, growth capex and liquidity are each a non-IFRS financial measure. For additional information on non-IFRS and other financial measures, see “Non-IFRS financial measures” below. 5 Please refer to the press releases issued by the Company relating to the filings for the June 30, 2025, March 31, 2025, December 31, 2024, and September 30, 2024 periods for the quantitative reconciliation.